Fielder Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Fielder Capital Group's LLY Position: Q2 2026 in Review
Fielder Capital Group increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $115K and bringing the position to 694 shares worth $832K. The position accounts for 0.18% of the portfolio, ranked #95.
Fielder Capital Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Fielder Capital Group held 694 shares of Eli Lilly worth $832K as of Q2 2026.
- Fielder Capital Group bought 113 Eli Lilly shares in Q2 2026, an estimated $115K.
- Eli Lilly made up 0.18% of Fielder Capital Group's portfolio in Q2 2026, its #95 holding.
- Fielder Capital Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Fielder Capital Group's 13F filing for Q2 2026, filed 6 Aug 2026.